Active Biotech AB (publ) (STO:ACTI)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.1788
-0.0042 (-2.30%)
Sep 1, 2025, 5:29 PM CET
-2.30%
Market Cap225.12M
Revenue (ttm)n/a
Net Income (ttm)-40.50M
Shares Out1.23B
EPS (ttm)-0.05
PE Ration/a
Forward PE268.00
Dividendn/a
Ex-Dividend Daten/a
Volume2,877,200
Average Volume5,545,865
Open0.1818
Previous Close0.1830
Day's Range0.1770 - 0.1830
52-Week Range0.0630 - 0.5170
Beta1.45
RSI48.44
Earnings DateAug 21, 2025

About Active Biotech AB

Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase Ib/IIa clinical trial to treat relapsed refractory multiple myeloma; Laquinimod, a mechanism which is in phase 1 for the treatment of severe inflammatory eye diseases, such as non-infectious uveitis; Tasquinimod, an orally active small molecule immunomodulator that blocks tumor-promoting signals in the bone marrow microenvir... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1983
Employees 6
Stock Exchange Nasdaq Stockholm
Ticker Symbol ACTI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.